General Information About Pancreatic Neuroendocrine Tumors (Islet Cell Tumors)
Stages of Pancreatic Neuroendocrine Tumors
Recurrent Pancreatic Neuroendocrine Tumors
Treatment Option Overview
Treatment Options for Pancreatic Neuroendocrine Tumors
To Learn More About Pancreatic Neuroendocrine Tumors (Islet Cell Tumors)
Changes to This Summary (02/06/2012)
Get More Information From NCI
About PDQ
General Information About Pancreatic Neuroendocrine Tumors (Islet Cell Tumors)
Pancreatic neuroendocrine tumors form in hormone-making cells (islet cells) of the pancreas.
The pancreas is a gland about 6 inches long that is shaped like a thin pear lying on its side. The wider end of the pancreas is called the head, the middle section is called the body, and the narrow end is called the tail. The pancreas lies behind the stomach and in front of the spine.
1
There are two kinds of cells in the pancreas:
- Endocrine pancreas cells make several kinds of hormones (chemicals that control the actions of certain cells or organs in the body), such as insulin to control blood sugar. They cluster together in many small groups (islets) throughout the pancreas. Endocrine pancreas cells are also called islet cells or islets of Langerhans.
- Exocrine pancreas cells make enzymes that are released into the small intestine to help the body digest food. Most of the pancreas is made of ducts with small sacs at the end of the ducts, which are lined with exocrine cells. This summary discusses islet cell tumors of the endocrine pancreas. See the PDQ summary on Pancreatic Cancer Treatment 2 for information on exocrine pancreatic cancer.
A pancreatic neuroendocrine tumor (NET) may also be called a pancreatic endocrine tumor (PET), islet cell tumor, islet cell carcinoma, or pancreatic carcinoid.
Pancreatic NETs are much less common than pancreatic exocrine tumors and have a better prognosis.
Pancreatic NETs may or may not cause symptoms.
Pancreatic NETs may be functional (the hormones that are released cause symptoms) or nonfunctional (the hormones that are released do not cause symptoms) tumors:
- Functional tumors make one or more hormones, such as gastrin, insulin, and glucagon, that cause symptoms. Most functional tumors are benign (not cancer).
- Nonfunctional tumors make substances that do not cause symptoms. Symptoms are caused by the tumor as it spreads and grows. Most nonfunctional tumors are malignant (cancer).
Most pancreatic NETs are functional tumors.
There are different kinds of functional pancreatic NETs.
Pancreatic NETs make different kinds of hormones such as gastrin, insulin, and glucagon. Functional pancreatic NETs include the following:
- Gastrinoma: A tumor that forms in cells that make gastrin. Gastrin is a hormone that causes the stomach to release an acid that helps digest food. Both gastrin and stomach acid are increased by gastrinomas. When increased stomach acid, stomach ulcers, and diarrhea are caused by a tumor that makes gastrin, it is called Zollinger-Ellison syndrome. A gastrinoma usually forms in the head of the pancreas and sometimes forms in the small intestine. Most gastrinomas are malignant (cancer).
- Insulinoma: A tumor that forms in cells that make insulin. Insulin is a hormone that controls the amount of glucose (sugar) in the blood. It moves glucose into the cells, where it can be used by the body for energy. Insulinomas are usually slow-growing tumors that rarely spread. An insulinoma forms in the head, body, or tail of the pancreas. Insulinomas are usually benign (not cancer).
- Glucagonoma: A tumor that forms in cells that make glucagon. Glucagon is a hormone that increases the amount of glucose in the blood. It causes the liver to break down glycogen. Too much glucagon causes hyperglycemia (high blood sugar). A glucagonoma usually forms in the tail of the pancreas. Most glucagonomas are malignant (cancer).
- Other types of tumors: There are other rare types of functional pancreatic NETs that make hormones, including hormones that control the balance of sugar, salt, and water in the body. These tumors include:
- VIPomas, which make vasoactive intestinal peptide. VIPoma may also be called Verner-Morrison syndrome.
- Somatostatinomas, which make somatostatin.
Having certain syndromes can increase the risk of pancreatic NETs.
Anything that increases your risk of getting a disease is called a risk factor. Having a risk factor does not mean that you will get cancer; not having risk factors doesn't mean that you will not get cancer. People who think they may be at risk should discuss this with their doctor.
Multiple endocrine neoplasia type 1 (MEN1) syndrome is a risk factor for pancreatic NETs.
Different types of pancreatic NETs have different signs and symptoms.
Symptoms can be caused by the growth of the tumor and/or by hormones the tumor makes. Some tumors may not cause symptoms. Conditions other than pancreatic NETs can cause the symptoms listed below. Talk to your doctor if any of these problems occur.
Signs and symptoms of a non-functional pancreatic NET
A non-functional pancreatic NET may grow for a long time without causing symptoms. It may grow large or spread to other parts of the body before it causes symptoms, such as:
- Diarrhea.
- Indigestion.
- A lump in the abdomen.
- Pain in the abdomen or back.
- Yellowing of the skin and whites of the eyes.
Signs and symptoms of a functional pancreatic NET
The symptoms of a functional pancreatic NET depend on the type of hormone being made.
Too much gastrin may cause:
- Stomach ulcers that keep coming back.
- Pain in the abdomen, which may spread to the back. The pain may come and go and it may go away after taking an antacid.
- The flow of stomach contents back into the esophagus (gastroesophageal reflux).
- Diarrhea.
Too much insulin may cause:
- Low blood sugar. This can cause blurred vision, headache, and feeling lightheaded, tired, weak, shaky, nervous, irritable, sweaty, confused, or hungry.
- Fast heartbeat.
Too much glucagon may cause:
- Skin rash on the face, stomach, or legs.
- High blood sugar. This can cause headaches, frequent urination, dry skin and mouth, or feeling hungry, thirsty, tired, or weak.
- Blood clots. Blood clots in the lung can cause shortness of breath, cough, or pain in the chest. Blood clots in the arm or leg can cause pain, swelling, warmth, or redness of the arm or leg.
- Diarrhea.
- Weight loss for no known reason.
- Sore tongue or sores at the corners of the mouth.
Too much vasoactive intestinal peptide (VIP) may cause:
- Very large amounts of watery diarrhea.
- Dehydration. This can cause feeling thirsty, making less urine, dry skin and mouth, headaches, dizziness, or feeling tired.
- Low potassium level in the blood. This can cause muscle weakness, aching, or cramps, numbness and tingling, frequent urination, fast heartbeat, and feeling confused or thirsty.
- Cramps or pain in the abdomen.
- Weight loss for no known reason.
Too much somatostatin may cause:
- High blood sugar. This can cause headaches, frequent urination, dry skin and mouth, or feeling hungry, thirsty, tired, or weak.
- Diarrhea.
- Steatorrhea (very foul-smelling stool that floats).
- Gallstones.
- Yellowing of the skin and whites of the eyes.
- Weight loss for no known reason.
Lab tests and imaging tests are used to detect (find) and diagnose pancreatic NETs.
The following tests and procedures may be used:
- Physical exam and history: An exam of the body to check general signs of health, including checking for signs of disease, such as lumps or anything else that seems unusual. A history of the patient’s health habits and past illnesses and treatments will also be taken.
- Blood chemistry studies: A procedure in which a blood sample is checked to measure the amounts of certain substances, such as glucose (sugar), released into the blood by organs and tissues in the body. An unusual (higher or lower than normal) amount of a substance can be a sign of disease in the organ or tissue that makes it.
- Immunohistochemistry study: A laboratory test in which a substance such as an antibody, dye, or radioisotope is added to a sample of cancer tissue to test for certain antigens. This type of study is used to tell the difference between different types of cancer.
- Abdominal CT scan (CAT scan): A procedure that makes a series of detailed pictures of the abdomen, taken from different angles. The pictures are made by a computer linked to an x-ray machine. A dye may be injected into a vein or swallowed to help the organs or tissues show up more clearly. This procedure is also called computed tomography, computerized tomography, or computerized axial tomography.
- MRI (magnetic resonance imaging): A procedure that uses a magnet, radio waves, and a computer to make a series of detailed pictures of areas inside the body. This procedure is also called nuclear magnetic resonance imaging (NMRI).
- Somatostatin receptor scintigraphy: A type of radionuclide scan that may be used to find small pancreatic NETs. A small amount of radioactive octreotide (a hormone that attaches to tumors) is injected into a vein and travels through the blood. The radioactive octreotide attaches to the tumor and a special camera that detects radioactivity is used to show where the tumors are in the body. This procedure is also called octreotide scan and SRS.
- Abdominal ultrasound: An ultrasound exam used to make pictures of the inside of the abdomen. The ultrasound transducer is pressed against the skin of the abdomen and directs high-energy sound waves (ultrasound) into the abdomen. The sound waves bounce off the internal tissues and organs and make echoes. The transducer receives the echoes and sends them to a computer, which uses the echoes to make pictures called sonograms. The picture can be printed to be looked at later.
- Endoscopic ultrasound (EUS): A procedure in which an endoscope is inserted into the body, usually through the mouth or rectum. An endoscope is a thin, tube-like instrument with a light and a lens for viewing. A probe at the end of the endoscope is used to bounce high-energy sound waves (ultrasound) off internal tissues or organs and make echoes. The echoes form a picture of body tissues called a sonogram. This procedure is also called endosonography.
- Angiogram: A procedure to look at blood vessels and the flow of blood. A contrast dye is injected into the blood vessel. As the contrast dye moves through the blood vessel, x-rays are taken to see if there are any blockages.
- Laparotomy: A surgical procedure in which an incision (cut) is made in the wall of the abdomen to check the inside of the abdomen for signs of disease. The size of the incision depends on the reason the laparotomy is being done. Sometimes organs are removed or tissue samples are taken and checked under a microscope for signs of disease.
- Intraoperative ultrasound: A procedure that uses high-energy sound waves (ultrasound) to create images of internal organs or tissues during surgery. A transducer placed directly on the organ or tissue is used to make the sound waves, which create echoes. The transducer receives the echoes and sends them to a computer, which uses the echoes to make pictures called sonograms.
- Biopsy: The removal of cells or tissues so they can be viewed under a microscope by a pathologist to check for signs of cancer. There are several ways to do a biopsy for pancreatic NETs. Cells may be removed using a fine or wide needle inserted into the pancreas during an x-ray or ultrasound. Tissue may also be removed during a laparoscopy (a surgical incision made in the wall of the abdomen).
- Bone scan: A procedure to check if there are rapidly dividing cells, such as cancer cells, in the bone. A very small amount of radioactive material is injected into a vein and travels through the blood. The radioactive material collects in bones where cancer cells have spread and is detected by a scanner.
Other kinds of lab tests are used to check for the specific type of pancreatic NETs.
The following tests and procedures may be used:
Gastrinoma
- Fasting serum gastrin test: A test in which a blood sample is checked to measure the amount of gastrin in the blood. This test is done after the patient has had nothing to eat or drink for at least 8 hours. Conditions other than gastrinoma can cause an increase in the amount of gastrin in the blood.
- Gastric acid secretion test: A test to measure the amount of acid made by the stomach. A tube is inserted through the nose or throat, into the stomach. Gastrin or insulin is injected into the patient, which causes the stomach to make stomach secretions (gastric acid). Four samples of gastric acid are taken through the tube 15 minutes apart. These four samples are used to find out the lowest and highest amounts of gastric acid made during the test and the pH level of the gastric secretions.
- Secretin stimulation test: If the gastric acid secretion test result is not normal, a secretin stimulation test may be done. The tube is moved into the small intestine and samples are taken from the small intestine after a drug called secretin is injected. Secretin causes the small intestine to make acid. When there is a gastrinoma, the secretin causes an increase in how much gastric acid is made and the level of gastrin in the blood.
- Calcium infusion test: A test to measure the amount of gastrin in the blood after a drug called calcium gluconate is infused. Blood samples will be taken to measure the amount of gastrin in the blood at set times.
- Somatostatin receptor scintigraphy: A type of radionuclide scan that may be used to find small pancreatic NETs. A small amount of radioactive octreotide (a hormone that attaches to tumors) is injected into a vein and travels through the blood. The radioactive octreotide attaches to the tumor and a special camera that detects radioactivity is used to show where the tumors are in the body. This procedure is also called octreotide scan and SRS.
Insulinoma
- Fasting serum glucose and insulin test: A test in which a blood sample is checked to measure the amounts of glucose (sugar) and insulin in the blood. The test is done after the patient has had nothing to eat or drink for at least 24 hours.
- C-peptide suppression test: A test in which a blood sample is checked to measure the amount of C-peptide in the blood. Insulin is injected into a vein to lower the patient’s blood sugar. This should decrease the amount of insulin and C-peptide that the body releases into the blood. In patients who have insulinoma, the insulin and C-peptide levels do not drop because the tumor is also releasing insulin and C-peptide into the blood.
Glucagonoma
- Fasting serum glucagon test: A test in which a blood sample is checked to measure the amount of glucagon in the blood. The test is done after the patient has had nothing to eat or drink for at least 8 hours.
Other tumor types
- VIPoma
- Serum VIP (vasoactive intestinal peptide) test: A test in which a blood sample is checked to measure the amount of VIP.
- Blood chemistry studies: A procedure in which a blood sample is checked to measure the amounts of certain substances released into the blood by organs and tissues in the body. An unusual (higher or lower than normal) amount of a substance can be a sign of disease in the organ or tissue that makes it. In VIPoma, there is a lower than normal amount of potassium.
- Stool analysis: A stool sample is checked for a higher than normal sodium (salt) and potassium levels.
- Somatostatinoma
- Fasting serum somatostatin test: A test in which a blood sample is checked to measure the amount of somatostatin in the blood. The test is done after the patient has had nothing to eat or drink for at least 8 hours.
- Somatostatin receptor scintigraphy: A type of radionuclide scan that may be used to find small pancreatic NETs. A small amount of radioactive octreotide (a hormone that attaches to tumors) is injected into a vein and travels through the blood. The radioactive octreotide attaches to the tumor and a special camera that detects radioactivity is used to show where the tumors are in the body. This procedure is also called octreotide scan and SRS.
Certain factors affect prognosis (chance of recovery) and treatment options.
Pancreatic NETs can often be cured. The prognosis (chance of recovery) and treatment options depend on the following:
- The type of cancer cell.
- Where the tumor is found in the pancreas.
- Whether the tumor has spread to more than one place in the pancreas or to other parts of the body.
- Whether the patient has MEN1 syndrome.
- The patient's age and general health.
- Whether the cancer has just been diagnosed or has recurred (come back).
Stages of Pancreatic Neuroendocrine Tumors
| Key Points for This Section |
|
The plan for cancer treatment depends on where the NET is found in the pancreas and whether it has spread.
The process used to find out if cancer has spread within the pancreas or to other parts of the body is called staging. The results of the tests and procedures used to diagnose pancreatic neuroendocrine tumors (NETs) are also used to find out whether the cancer has spread. See the General Information 3 section for a description of these tests and procedures.
Although there is a standard staging system for pancreatic NETs, it is not used to plan treatment. Treatment of pancreatic NETs is based on the following:
- Whether the cancer is found in one place in the pancreas.
- Whether the cancer is found in several places in the pancreas.
- Whether the cancer has spread to lymph nodes near the pancreas or to other parts of the body such as the liver, lung, peritoneum, or bone.
There are three ways that cancer spreads in the body.
The three ways that cancer spreads in the body are:
- Through tissue. Cancer invades the surrounding normal tissue.
- Through the lymph system. Cancer invades the lymph system and travels through the lymph vessels to other places in the body.
- Through the blood. Cancer invades the veins and capillaries and travels through the blood to other places in the body.
When cancer cells break away from the primary (original) tumor and travel through the lymph or blood to other places in the body, another (secondary) tumor may form. This process is called metastasis. The secondary (metastatic) tumor is the same type of cancer as the primary tumor. For example, if breast cancer spreads to the bones, the cancer cells in the bones are actually breast cancer cells. The disease is metastatic breast cancer, not bone cancer.
Recurrent Pancreatic Neuroendocrine Tumors
Recurrent pancreatic neuroendocrine tumors (NETs) are tumors that have recurred (come back) after being treated. The tumors may come back in the pancreas or in other parts of the body.
Treatment Option Overview
There are different types of treatment for patients with pancreatic NETs.
Different types of treatments are available for patients with pancreatic neuroendocrine tumors (NETs). Some treatments are standard (the currently used treatment), and some are being tested in clinical trials. A treatment clinical trial is a research study meant to help improve current treatments or obtain information on new treatments for patients with cancer. When clinical trials show that a new treatment is better than the standard treatment, the new treatment may become the standard treatment. Patients may want to think about taking part in a clinical trial. Some clinical trials are open only to patients who have not started treatment.
Six types of standard treatment are used:
An operation may be done to remove the tumor. One of the following types of surgery may be used:
- Enucleation: Surgery to remove the tumor only. This may be done when cancer occurs in one place in the pancreas.
- Pancreatoduodenectomy: A surgical procedure in which the head of the pancreas, the gallbladder, nearby lymph nodes and part of the stomach, small intestine, and bile duct are removed. Enough of the pancreas is left to make digestive juices and insulin. The organs removed during this procedure depend on the patient's condition. This is also called the Whipple procedure.
- Distal pancreatectomy: Surgery to remove the body and tail of the pancreas. The spleen may also be removed.
- Total gastrectomy: Surgery to remove the whole stomach.
- Parietal cell vagotomy: Surgery to cut the nerve that causes stomach cells to make acid.
- Liver resection: Surgery to remove part or all of the liver.
- Radiofrequency ablation: The use of a special probe with tiny electrodes that kill cancer cells. Sometimes the probe is inserted directly through the skin and only local anesthesia is needed. In other cases, the probe is inserted through an incision in the abdomen. This is done in the hospital with general anesthesia.
- Cryosurgical ablation: A procedure in which tissue is frozen to destroy abnormal cells. This is usually done with a special instrument that contains liquid nitrogen or liquid carbon dioxide. The instrument may be used during surgery or laparoscopy or inserted through the skin. This procedure is also called cryoablation.
Chemotherapy is a cancer treatment that uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. When chemotherapy is taken by mouth or injected into a vein or muscle, the drugs enter the bloodstream and can reach cancer cells throughout the body (systemic chemotherapy). When chemotherapy is placed directly into the cerebrospinal fluid, an organ, or a body cavity such as the abdomen, the drugs mainly affect cancer cells in those areas (regional chemotherapy). Combination chemotherapy is the use of more than one anticancer drug. The way the chemotherapy is given depends on the type of the cancer being treated.
Hormone therapy is a cancer treatment that removes hormones or blocks their action and stops cancer cells from growing. Hormones are substances made by glands in the body and circulated in the bloodstream. Some hormones can cause certain cancers to grow. If tests show that the cancer cells have places where hormones can attach (receptors), drugs, surgery, or radiation therapy is used to reduce the production of hormones or block them from working.
Hepatic arterial occlusion or chemoembolization
Hepatic arterial occlusion uses drugs, small particles, or other agents to block or reduce the flow of blood to the liver through the hepatic artery (the major blood vessel that carries blood to the liver). This is done to kill cancer cells growing in the liver. The tumor is prevented from getting the oxygen and nutrients it needs to grow. The liver continues to receive blood from the hepatic portal vein, which carries blood from the stomach and intestine.
Chemotherapy delivered during hepatic arterial occlusion is called chemoembolization. The anticancer drug is injected into the hepatic artery through a catheter (thin tube). The drug is mixed with the substance that blocks the artery and cuts off blood flow to the tumor. Most of the anticancer drug is trapped near the tumor and only a small amount of the drug reaches other parts of the body.
The blockage may be temporary or permanent, depending on the substance used to block the artery.
Targeted therapy is a type of treatment that uses drugs or other substances to identify and attack specific cancer cells without harming normal cells. Certain types of targeted therapies are being studied in the treatment of pancreatic NETs.
Supportive care is given to lessen the problems caused by the disease or its treatment. Supportive care for pancreatic NETs may include treatment for the following:
- Stomach ulcers may be treated with drug therapy such as:
- Proton pump inhibitor drugs such as omeprazole, lansoprazole, or pantoprazole.
- Histamine blocking drugs such as cimetidine, ranitidine, or famotidine.
- Somatostatin-type drugs such as octreotide.
- Diarrhea may be treated with:
- Intravenous (IV) fluids with electrolytes such as potassium or chloride.
- Somatostatin-type drugs such as octreotide.
- Low blood sugar may be treated by having small, frequent meals or with drug therapy to maintain a normal blood sugar level.
- High blood sugar may be treated with drugs taken by mouth or insulin by injection.
New types of treatment are being tested in clinical trials.
Information about clinical trials is available from the NCI Web site 4.
Patients may want to think about taking part in a clinical trial.
For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer treatments are safe and effective or better than the standard treatment.
Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment.
Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.
Patients can enter clinical trials before, during, or after starting their cancer treatment.
Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the side effects of cancer treatment.
Clinical trials are taking place in many parts of the country. See the Treatment Options section that follows for links to current treatment clinical trials. These have been retrieved from NCI's listing of clinical trials.
Follow-up tests may be needed.
Some of the tests that were done to diagnose the cancer or to find out the stage of the cancer may be repeated. Some tests will be repeated in order to see how well the treatment is working. Decisions about whether to continue, change, or stop treatment may be based on the results of these tests. This is sometimes called re-staging.
Some of the tests will continue to be done from time to time after treatment has ended. The results of these tests can show if your condition has changed or if the cancer has recurred (come back). These tests are sometimes called follow-up tests or check-ups.
Treatment Options for Pancreatic Neuroendocrine Tumors
A link to a list of current clinical trials is included for each treatment section. For some types or stages of cancer, there may not be any trials listed. Check with your doctor for clinical trials that are not listed here but may be right for you.
GastrinomaTreatment of gastrinoma may include supportive care 5 and the following:
- For symptoms caused by too much stomach acid, treatment may be a drug that decreases the amount of acid made by the stomach.
- For a single tumor in the head of the pancreas:
- Surgery to remove the tumor.
- Surgery to cut the nerve that causes stomach cells to make acid and treatment with a drug that decreases stomach acid.
- Surgery to remove the whole stomach (rare).
- For a single tumor in the body or tail of the pancreas, treatment is usually surgery to remove the body or tail of the pancreas.
- For several tumors in the pancreas, treatment is usually surgery to remove the body or tail of the pancreas. If tumor remains after surgery, treatment may include either:
- Surgery to cut the nerve that causes stomach cells to make acid and treatment with a drug that decreases stomach acid; or
- Surgery to remove the whole stomach (rare).
- For one or more tumors in the duodenum (the part of the small intestine that connects to the stomach), treatment is usually pancreatoduodenectomy (surgery to remove the head of the pancreas, the gallbladder, nearby lymph nodes and part of the stomach, small intestine, and bile duct).
- If no tumor is found, treatment may include the following:
- Surgery to cut the nerve that causes stomach cells to make acid and treatment with a drug that decreases stomach acid.
- Surgery to remove the whole stomach (rare).
- If the cancer has spread to the liver, treatment may include:
- Surgery to remove part or all of the liver.
- Radiofrequency ablation or cryosurgical ablation.
- Chemoembolization.
- If cancer has spread to other parts of the body or does not get better with surgery or drugs to decrease stomach acid, treatment may include:
- If the cancer mostly affects the liver and the patient has severe symptoms from hormones or from the size of tumor, treatment may include:
- Hepatic arterial occlusion, with or without systemic chemotherapy.
- Chemoembolization, with or without systemic chemotherapy.
Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with gastrinoma 6. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site 7.
InsulinomaTreatment of insulinoma may include the following:
- For one small tumor in the head or tail of the pancreas, treatment is usually surgery to remove the tumor.
- For one large tumor in the head of the pancreas that cannot be removed by surgery, treatment is usually pancreatoduodenectomy (surgery to remove the head of the pancreas, the gallbladder, nearby lymph nodes and part of the stomach, small intestine, and bile duct).
- For one large tumor in the body or tail of the pancreas, treatment is usually a distal pancreatectomy (surgery to remove the body and tail of the pancreas).
- For more than one tumor in the pancreas, treatment is usually surgery to remove any tumors in the head of the pancreas and the body and tail of the pancreas.
- For tumors that have spread to lymph nodes or other parts of the body, treatment may include the following:
- Surgery to remove the tumor.
- Radiofrequency ablation or cryosurgical ablation, if the tumor cannot be removed by surgery.
- For tumors that cannot be removed by surgery, treatment may include the following:
- Combination chemotherapy.
- Palliative drug therapy to decrease the amount of insulin made by the pancreas.
- Hormone therapy.
- Radiofrequency ablation or cryosurgical ablation.
- If the cancer mostly affects the liver and the patient has severe symptoms from hormones or from the size of tumor, treatment may include:
- Hepatic arterial occlusion, with or without systemic chemotherapy.
- Chemoembolization, with or without systemic chemotherapy.
Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with insulinoma 8. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site 7.
GlucagonomaTreatment may include the following:
- For one small tumor in the head or tail of the pancreas, treatment is usually surgery to remove the tumor.
- For one large tumor in the head of the pancreas that cannot be removed by surgery, treatment is usually pancreatoduodenectomy (surgery to remove the head of the pancreas, the gallbladder, nearby lymph nodes and part of the stomach, small intestine, and bile duct).
- For more than one tumor in the pancreas, treatment is usually surgery to remove the tumor or surgery to remove the body and tail of the pancreas.
- For tumors that have spread to lymph nodes or other parts of the body, treatment may include the following:
- Surgery to remove the tumor.
- Radiofrequency ablation or cryosurgical ablation, if the tumor cannot be removed by surgery.
- For tumors that cannot be removed by surgery, treatment may include the following:
- Combination chemotherapy.
- Hormone therapy.
- Radiofrequency ablation or cryosurgical ablation.
- If the cancer mostly affects the liver and the patient has severe symptoms from hormones or from the size of tumor, treatment may include:
- Hepatic arterial occlusion, with or without systemic chemotherapy.
- Chemoembolization, with or without systemic chemotherapy.
Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with glucagonoma 9. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site 7.
Other Pancreatic Neuroendocrine Tumors (Islet Cell Tumors)For VIPoma, treatment may include the following:
- Fluids and hormone therapy to replace fluids and electrolytes that have been lost from the body.
- Surgery to remove the tumor and nearby lymph nodes.
- Surgery to remove as much of the tumor as possible when the tumor cannot be completely removed or has spread to distant parts of the body. This is palliative therapy to relieve symptoms and improve the quality of life.
- For tumors that have spread to lymph nodes or other parts of the body, treatment may include the following:
- Surgery to remove the tumor.
- Radiofrequency ablation or cryosurgical ablation, if the tumor cannot be removed by surgery.
- For tumors that continue to grow during treatment or have spread to other parts of the body, treatment may include the following:
For somatostatinoma, treatment may include the following:
- Surgery to remove the tumor.
- For tumors that have spread to distant parts of the body, surgery to remove as much of the tumor as possible to relieve symptoms and improve quality of life.
- For tumors that continue to grow during treatment or have spread to other parts of the body, treatment may include the following:
- Chemotherapy.
- Targeted therapy.
Treatment of other types of pancreatic neuroendocrine tumors (NETs) may include the following:
- Surgery to remove the tumor.
- For tumors that have spread to distant parts of the body, surgery to remove as much of the tumor as possible or hormone therapy to relieve symptoms and improve quality of life.
- For tumors that continue to grow during treatment or have spread to other parts of the body, treatment may include the following:
- Chemotherapy.
- Targeted therapy.
Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with islet cell tumor 10. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site 7.
Recurrent or Progressive Pancreatic Neuroendocrine Tumors (Islet Cell Tumors)Treatment of pancreatic neuroendocrine tumors (NETs) that continue to grow during treatment or recur (come back) may include the following:
- Surgery to remove the tumor.
- Chemotherapy.
- Hormone therapy.
- Targeted therapy.
- For liver metastases:
- Regional chemotherapy.
- Hepatic arterial occlusion or chemoembolization, with or without systemic chemotherapy.
- A clinical trial of a new therapy.
Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with recurrent islet cell carcinoma 11. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site 7.
To Learn More About Pancreatic Neuroendocrine Tumors (Islet Cell Tumors)
For more information from the National Cancer Institute about pancreatic neuroendocrine tumors (NETs), see the following:
- Pancreatic Cancer Home Page 12
- Understanding Cancer Series: Targeted Therapies 13 (Advances in Targeted Therapies)
- Targeted Cancer Therapies 14
For general cancer information and other resources from the National Cancer Institute, see the following:
- What You Need to Know About™ Cancer 15
- Understanding Cancer Series: Cancer 16
- Cancer Staging 17
- Chemotherapy and You: Support for People With Cancer 18
- Radiation Therapy and You: Support for People With Cancer 19
- Coping with Cancer: Supportive and Palliative Care 20
- Questions to Ask Your Doctor About Cancer 21
- Cancer Library 22
- Information For Survivors/Caregivers/Advocates 23
Changes to This Summary (02/06/2012)
The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.
Editorial changes were made to this summary.
Get More Information From NCI
Call 1-800-4-CANCER
For more information, U.S. residents may call the National Cancer Institute's (NCI's) Cancer Information Service toll-free at 1-800-4-CANCER (1-800-422-6237) Monday through Friday from 8:00 a.m. to 8:00 p.m., Eastern Time. A trained Cancer Information Specialist is available to answer your questions.
Chat online
The NCI's LiveHelp® 24 online chat service provides Internet users with the ability to chat online with an Information Specialist. The service is available from 8:00 a.m. to 11:00 p.m. Eastern time, Monday through Friday. Information Specialists can help Internet users find information on NCI Web sites and answer questions about cancer.
Write to us
For more information from the NCI, please write to this address:
- NCI Public Inquiries Office
- Suite 3036A
- 6116 Executive Boulevard, MSC8322
- Bethesda, MD 20892-8322
Search the NCI Web site
The NCI Web site 25 provides online access to information on cancer, clinical trials, and other Web sites and organizations that offer support and resources for cancer patients and their families. For a quick search, use the search box in the upper right corner of each Web page. The results for a wide range of search terms will include a list of "Best Bets," editorially chosen Web pages that are most closely related to the search term entered.
There are also many other places to get materials and information about cancer treatment and services. Hospitals in your area may have information about local and regional agencies that have information on finances, getting to and from treatment, receiving care at home, and dealing with problems related to cancer treatment.
Find Publications
The NCI has booklets and other materials for patients, health professionals, and the public. These publications discuss types of cancer, methods of cancer treatment, coping with cancer, and clinical trials. Some publications provide information on tests for cancer, cancer causes and prevention, cancer statistics, and NCI research activities. NCI materials on these and other topics may be ordered online or printed directly from the NCI Publications Locator 26. These materials can also be ordered by telephone from the Cancer Information Service toll-free at 1-800-4-CANCER (1-800-422-6237).
About PDQ
PDQ is a comprehensive cancer database available on NCI's Web site.
PDQ is the National Cancer Institute's (NCI's) comprehensive cancer information database. Most of the information contained in PDQ is available online at NCI's Web site 25. PDQ is provided as a service of the NCI. The NCI is part of the National Institutes of Health, the federal government's focal point for biomedical research.
PDQ contains cancer information summaries.
The PDQ database contains summaries of the latest published information on cancer prevention, detection, genetics, treatment, supportive care, and complementary and alternative medicine. Most summaries are available in two versions. The health professional versions provide detailed information written in technical language. The patient versions are written in easy-to-understand, nontechnical language. Both versions provide current and accurate cancer information.
The PDQ cancer information summaries are developed by cancer experts and reviewed regularly.
Editorial Boards made up of experts in oncology and related specialties are responsible for writing and maintaining the cancer information summaries. The summaries are reviewed regularly and changes are made as new information becomes available. The date on each summary ("Date Last Modified") indicates the time of the most recent change.
PDQ also contains information on clinical trials.
A clinical trial is a study to answer a scientific question, such as whether one treatment is better than another. Trials are based on past studies and what has been learned in the laboratory. Each trial answers certain scientific questions in order to find new and better ways to help cancer patients. During treatment clinical trials, information is collected about the effects of a new treatment and how well it works. If a clinical trial shows that a new treatment is better than one currently being used, the new treatment may become "standard." Patients may want to think about taking part in a clinical trial. Some clinical trials are open only to patients who have not started treatment.
Listings of clinical trials are included in PDQ and are available online at NCI's Web site 7. Descriptions of the trials are available in health professional and patient versions. Many cancer doctors who take part in clinical trials are also listed in PDQ. For more information, call the Cancer Information Service 1-800-4-CANCER (1-800-422-6237).
Glossary Termsabdomen (AB-doh-men)The area of the body that contains the pancreas, stomach, intestines, liver, gallbladder, and other organs.abdominal (ab-DAH-mih-nul) Having to do with the abdomen, which is the part of the body between the chest and the hips that contains the pancreas, stomach, intestines, liver, gallbladder, and other organs.acid (A-sid) A chemical that gives off hydrogen ions in water and forms salts by combining with certain metals. Acids have a sour taste and turn certain dyes red. Some acids made by the body, such as gastric acid, can help organs work the way they should. An example of an acid is hydrochloric acid. Acidity is measured on a scale called the pH scale. On this scale, a value of 7 is neutral, and a pH value of less than 7 to 0 shows increasing acidity.analysis (uh-NA-lih-sis) A process in which anything complex is separated into simple or less complex parts.angiogram (AN-jee-oh-gram) An x-ray of blood vessels. The person receives an injection of dye to outline the vessels on the x-ray.antibody (AN-tee-BAH-dee) A protein made by plasma cells (a type of white blood cell) in response to an antigen (a substance that causes the body to make a specific immune response). Each antibody can bind to only one specific antigen. The purpose of this binding is to help destroy the antigen. Some antibodies destroy antigens directly. Others make it easier for white blood cells to destroy the antigen.antigen (AN-tih-jen) Any substance that causes the body to make a specific immune response.benign (beh-NINE) Not cancerous. Benign tumors may grow larger but do not spread to other parts of the body. Also called nonmalignant.biopsy (BY-op-see) The removal of cells or tissues for examination by a pathologist. The pathologist may study the tissue under a microscope or perform other tests on the cells or tissue. There are many different types of biopsy procedures. The most common types include: (1) incisional biopsy, in which only a sample of tissue is removed; (2) excisional biopsy, in which an entire lump or suspicious area is removed; and (3) needle biopsy, in which a sample of tissue or fluid is removed with a needle. When a wide needle is used, the procedure is called a core biopsy. When a thin needle is used, the procedure is called a fine-needle aspiration biopsy.blood (blud) A tissue with red blood cells, white blood cells, platelets, and other substances suspended in fluid called plasma. Blood takes oxygen and nutrients to the tissues, and carries away wastes.blood chemistry study (blud KEH-mih-stree STUH-dee) A procedure in which a sample of blood is examined to measure the amounts of certain substances made in the body. An abnormal amount of a substance can be a sign of disease in the organ or tissue that produces it.blood clot (blud klot) A mass of blood that forms when blood platelets, proteins, and cells stick together. When a blood clot is attached to the wall of a blood vessel, it is called a thrombus. When it moves through the bloodstream and blocks the flow of blood in another part of the body, it is called an embolus.blood sugar (blud SHUH-ger) Glucose (a type of sugar) found in the blood. Also called glycemia.blood vessel (blud VEH-sel) A tube through which the blood circulates in the body. Blood vessels include a network of arteries, arterioles, capillaries, venules, and veins.bone scan (bone skan) A technique to create images of bones on a computer screen or on film. A small amount of radioactive material is injected into a blood vessel and travels through the bloodstream; it collects in the bones and is detected by a scanner.C-peptide (… PEP-tide) A substance made by the pancreas. C-peptide and insulin are both part of a larger molecule that gets split apart before being released into the blood. Abnormal blood levels of C-peptide may occur in certain diseases, such as diabetes or cancer. Also called connecting peptide.C-peptide suppression test (… PEP-tide suh-PREH-shun …) A test used to help diagnose a type of pancreatic tumor called an insulinoma. After fasting, the patient receives an injection of insulin and the level of C-peptide (a substance released with insulin by the pancreas) in the blood is measured. In patients who have an insulinoma, the level of C-peptide is higher than normal.calcium gluconate (KAL-see-um GLOO-koh-nayt) The mineral calcium combined with a form of the sugar glucose. It is used to prevent and treat osteoporosis (a decrease in bone mass and density). It is also being studied in the treatment of bone loss and nerve damage caused by chemotherapy. It is a type of dietary supplement.calcium infusion test (KAL-see-um in-FYOO-zhun …) A test used to help diagnose a type of pancreatic islet cell tumor called a gastrinoma. The patient receives a 3-hour infusion of a substance called calcium gluconate and the amount of gastrin in the blood is measured. An increase in the level of gastrin in the blood after the infusion may be a sign of a gastrinoma.cancer (KAN-ser) A term for diseases in which abnormal cells divide without control and can invade nearby tissues. Cancer cells can also spread to other parts of the body through the blood and lymph systems. There are several main types of cancer. Carcinoma is a cancer that begins in the skin or in tissues that line or cover internal organs. Sarcoma is a cancer that begins in bone, cartilage, fat, muscle, blood vessels, or other connective or supportive tissue. Leukemia is a cancer that starts in blood-forming tissue such as the bone marrow, and causes large numbers of abnormal blood cells to be produced and enter the blood. Lymphoma and multiple myeloma are cancers that begin in the cells of the immune system. Central nervous system cancers are cancers that begin in the tissues of the brain and spinal cord. Also called malignancy.cell (sel) The individual unit that makes up the tissues of the body. All living things are made up of one or more cells.clinical trial (KLIH-nih-kul TRY-ul) A type of research study that tests how well new medical approaches work in people. These studies test new methods of screening, prevention, diagnosis, or treatment of a disease. Also called clinical study.condition (kun-DIH-shun) In medicine, a health problem with certain characteristics or symptoms.contrast material (KON-trast muh-TEER-ee-ul) A dye or other substance that helps show abnormal areas inside the body. It is given by injection into a vein, by enema, or by mouth. Contrast material may be used with x-rays, CT scans, MRI, or other imaging tests.CT scan (… skan) A series of detailed pictures of areas inside the body taken from different angles. The pictures are created by a computer linked to an x-ray machine. Also called CAT scan, computed tomography scan, computerized axial tomography scan, and computerized tomography.cure (kyoor) To heal or restore health; a treatment to restore health.dehydration (dee-hy-DRAY-shun) A condition caused by the loss of too much water from the body. Severe diarrhea or vomiting can cause dehydration.diagnosis (DY-ug-NOH-sis) The process of identifying a disease, such as cancer, from its signs and symptoms.diarrhea (dy-uh-REE-uh) Frequent and watery bowel movements.digestion (dy-JES-chun) The process of breaking down food into substances the body can use for energy, tissue growth, and repair.drug (drug) Any substance, other than food, that is used to prevent, diagnose, treat or relieve symptoms of a disease or abnormal condition. Also refers to a substance that alters mood or body function, or that can be habit-forming or addictive, especially a narcotic.duct (dukt) In medicine, a tube or vessel of the body through which fluids pass.endocrine pancreas cell (EN-doh-krin PAN-kree-us sel) A pancreatic cell that produces hormones (e.g., insulin and glucagon) that are secreted into the bloodstream. These hormones help control the level of glucose (sugar) in the blood. Also called islet cell and islet of Langerhans cell.endoscope (EN-doh-SKOPE) A thin, tube-like instrument used to look at tissues inside the body. An endoscope has a light and a lens for viewing and may have a tool to remove tissue.endoscopic ultrasound (en-doh-SKAH-pik...) A procedure in which an endoscope is inserted into the body. An endoscope is a thin, tube-like instrument that has a light and a lens for viewing. A probe at the end of the endoscope is used to bounce high-energy sound waves (ultrasound) off internal organs to make a picture (sonogram). Also called endosonography and EUS.enzyme (EN-zime) A protein that speeds up chemical reactions in the body.esophagus (ee-SAH-fuh-gus) The muscular tube through which food passes from the throat to the stomach.exocrine cancer (EK-soh-krin KAN-ser) A disease in which malignant (cancer) cells are found in the tissues of the pancreas. Also called pancreatic cancer.exocrine pancreas cell (EK-soh-krin PAN-kree-us sel) A pancreatic cell that produces enzymes that are secreted into the small intestine. These enzymes help digest food as it passes through the gastrointestinal tract.functioning tumor (FUNK-shuh-ning TOO-mer) A tumor that is found in endocrine tissue and makes hormones (chemicals that travel in the bloodstream and control the actions of other cells or organs).gallstone (GAWL-stone) Solid material that forms in the gallbladder or common bile duct. Gallstones are made of cholesterol or other substances found in the gallbladder. They may occur as one large stone or as many small ones, and vary from the size of a golf ball to a grain of sand. Also called cholelith.gastric (GAS-trik) Having to do with the stomach.gastric acid (GAS-trik A-sid) Acid that is released into the stomach from glands in the stomach wall. It helps digest food. Gastric acid is made of hydrochloric acid.gastric acid secretion test (GAS-trik A-sid seh-KREE-shun …) A test used to measure the amount of gastric acid made by the stomach. The patient receives an injection of the hormone gastrin or insulin. A tube is put through the nose or throat into the stomach and samples are taken from the stomach and sent to a laboratory for testing. Also called stomach acid stimulation test and stomach acid test.gastrin (GAS-trin) A hormone released from special cells in the lining of the stomach after eating. Gastrin causes the stomach to release an acid that helps digest food.gastrinoma (gas-trih-NOH-muh) A tumor that causes overproduction of gastric acid. It usually begins in the duodenum (first part of the small intestine that connects to the stomach) or the islet cells of the pancreas. Rarely, it may also begin in other organs, including the stomach, liver, jejunum (the middle part of the small intestine), biliary tract (organs and ducts that make and store bile), mesentery, or heart. It is a type of neuroendocrine tumor, and it may metastasize (spread) to the liver and the lymph nodes.gastroesophageal reflux (GAS-troh-ee-SAH-fuh-JEE-ul REE-flux) The backward flow of stomach acid contents into the esophagus (the tube that connects the mouth to the stomach). Also called esophageal reflux and gastric reflux.gland (gland) An organ that makes one or more substances, such as hormones, digestive juices, sweat, tears, saliva, or milk. Endocrine glands release the substances directly into the bloodstream. Exocrine glands release the substances into a duct or opening to the inside or outside of the body.glucagon (GLOO-kuh-gon) A hormone produced by the pancreas that increases the level of glucose (sugar) in the blood.glucagonoma (GLOO-kuh-guh-NOH-ma) A rare pancreatic tumor that produces a hormone called glucagon. Glucagonomas can produce symptoms similar to diabetes.glucose (GLOO-kose) A type of sugar; the chief source of energy for living organisms.high blood sugar (hy blud SHUH-ger) Higher than normal amount of glucose (a type of sugar) in the blood. High blood sugar can be a sign of diabetes or other conditions. Also called hyperglycemia.hormone (HOR-mone) One of many chemicals made by glands in the body. Hormones circulate in the bloodstream and control the actions of certain cells or organs. Some hormones can also be made in the laboratory.hyperglycemia (HY-per-gly-SEE-mee-uh) Higher than normal amount of glucose (a type of sugar) in the blood. Hyperglycemia can be a sign of diabetes or other conditions. Also called high blood sugar.immunohistochemistry (IH-myoo-noh-HIS-toh-KEH-mih-stree) A technique used to identify specific molecules in different kinds of tissue. The tissue is treated with antibodies that bind the specific molecule. These are made visible under a microscope by using a color reaction, a radioisotope, colloidal gold, or a fluorescent dye. Immunohistochemistry is used to help diagnose diseases, such as cancer, and to detect the presence of microorganisms. It is also used in basic research to understand how cells grow and differentiate (become more specialized).incision (in-SIH-zhun) A cut made in the body to perform surgery.infusion (in-FYOO-zhun) A method of putting fluids, including drugs, into the bloodstream. Also called intravenous infusion.injection (in-JEK-shun) Use of a syringe and needle to push fluids or drugs into the body; often called a "shot."insulin (IN-suh-lin) A hormone made by the islet cells of the pancreas. Insulin controls the amount of sugar in the blood by moving it into the cells, where it can be used by the body for energy.insulinoma (IN-suh-lih-NOH-muh) An abnormal mass that grows in the beta cells of the pancreas that make insulin. Insulinomas are usually benign (not cancer). They secrete insulin and are the most common cause of low blood sugar caused by having too much insulin in the body. Also called beta cell neoplasm, beta cell tumor of the pancreas, and pancreatic insulin-producing tumor.intraoperative ultrasound (IN-truh-AH-pruh-tiv UL-truh-SOWND) A procedure that uses ultrasound (high-energy sound waves that are bounced off internal tissues and organs) during surgery. Sonograms (pictures made by ultrasound) of the inside of the body are viewed on a computer to help a surgeon find tumors or other problems during the operation. Also called IOUS.islet cell (I-let sel) A pancreatic cell that produces hormones (e.g., insulin and glucagon) that are secreted into the bloodstream. These hormones help control the level of glucose (sugar) in the blood. Also called endocrine pancreas cell and islet of Langerhans cell.islet cell tumor (I-let sel TOO-mer) A mass of abnormal cells that forms in the endocrine (hormone-producing) tissues of the pancreas. Islet cell tumors may be benign (not cancer) or malignant (cancer).laboratory test (LA-bruh-tor-ee...) A medical procedure that involves testing a sample of blood, urine, or other substance from the body. Tests can help determine a diagnosis, plan treatment, check to see if treatment is working, or monitor the disease over time.laparoscopy (LA-puh-ROS-koh-pee) A procedure that uses a laparoscope, inserted through the abdominal wall, to examine the inside of the abdomen. A laparoscope is a thin, tube-like instrument with a light and a lens for viewing. It may also have a tool to remove tissue to be checked under a microscope for signs of disease.laparotomy (LA-puh-RAH-toh-mee) A surgical incision made in the wall of the abdomen.lens (lenz) A clear disk that focuses light, as in a camera or microscope. In the eye, the lens is a clear, curved structure at the front of the eye behind the pupil. It focuses light rays that enter the eye through the pupil, making an image on the retina (light-sensitive layers of nerve tissue at the back of the eye).liver (LIH-ver) A large organ located in the upper abdomen. The liver cleanses the blood and aids in digestion by secreting bile.lung (lung) One of a pair of organs in the chest that supplies the body with oxygen, and removes carbon dioxide from the body.malignant (muh-LIG-nunt) Cancerous. Malignant cells can invade and destroy nearby tissue and spread to other parts of the body.medical history (MEH-dih-kul HIH-stuh-ree) A record of information about a person’s health. A personal medical history may include information about allergies, illnesses, surgeries, immunizations, and results of physical exams and tests. It may also include information about medicines taken and health habits, such as diet and exercise. A family medical history includes health information about a person’s close family members (parents, grandparents, children, brothers, and sisters). This includes their current and past illnesses. A family medical history may show a pattern of certain diseases in a family.microscope (MY-kroh-SKOPE) An instrument that is used to look at cells and other small objects that cannot be seen with the eye alone.MRI A procedure in which radio waves and a powerful magnet linked to a computer are used to create detailed pictures of areas inside the body. These pictures can show the difference between normal and diseased tissue. MRI makes better images of organs and soft tissue than other scanning techniques, such as computed tomography (CT) or x-ray. MRI is especially useful for imaging the brain, the spine, the soft tissue of joints, and the inside of bones. Also called magnetic resonance imaging, NMRI, and nuclear magnetic resonance imaging.multiple endocrine neoplasia type 1 syndrome (MUL-tih-pul EN-doh-krin NEE-oh-PLAY-zhuh ... SIN-drome) A rare, inherited disorder that affects the endocrine glands and can cause tumors in the parathyroid and pituitary glands and the pancreas. These tumors are usually benign (not cancer). They cause the glands to secrete high levels of hormones, which can lead to other medical problems, such as kidney stones, fertility problems, and severe ulcers. In some cases, tumors inside the pancreas can become malignant (cancer). Also called MEN1 syndrome, multiple endocrine adenomatosis, and Wermer syndrome.neuroendocrine tumor (NOOR-oh-EN-doh-krin TOO-mer) A tumor that forms from cells that release hormones in response to a signal from the nervous system. Some examples of neuroendocrine tumors are carcinoid tumors, islet cell tumors, medullary thyroid carcinomas, pheochromocytomas, and neuroendocrine carcinomas of the skin (Merkel cell cancer). These tumors may secrete higher-than-normal amounts of hormones, which can cause many different symptoms.nonfunctioning tumor (non-FUNK-shuh-ning TOO-mer) A tumor that is found in endocrine tissue but does not make extra hormones. Nonfunctioning tumors usually do not cause symptoms until they grow large or spread to other parts of the body. Also called endocrine-inactive tumor.octreotide (ok-TREE-oh-tide) A drug similar to the naturally occurring growth hormone inhibitor somatostatin. Octreotide is used to treat diarrhea and flushing associated with certain types of tumors.organ (OR-gun) A part of the body that performs a specific function. For example, the heart is an organ.pancreas (PAN-kree-us) A glandular organ located in the abdomen. It makes pancreatic juices, which contain enzymes that aid in digestion, and it produces several hormones, including insulin. The pancreas is surrounded by the stomach, intestines, and other organs.pancreatic (PAN-kree-A-tik) Having to do with the pancreas.pathologist (puh-THAH-loh-jist) A doctor who identifies diseases by studying cells and tissues under a microscope.PDQ PDQ is an online database developed and maintained by the National Cancer Institute. Designed to make the most current, credible, and accurate cancer information available to health professionals and the public, PDQ contains peer-reviewed summaries on cancer treatment, screening, prevention, genetics, complementary and alternative medicine, and supportive care; a registry of cancer clinical trials from around the world; and directories of physicians, professionals who provide genetics services, and organizations that provide cancer care. Most of this information, and more specific information about PDQ, can be found on the NCI's Web site at http://www.cancer.gov/cancertopics/pdq. Also called Physician Data Query.physical examination (FIH-zih-kul eg-ZA-mih-NAY-shun) An exam of the body to check for general signs of disease.potassium (puh-TA-see-um) A metallic element that is important in body functions such as regulation of blood pressure and of water content in cells, transmission of nerve impulses, digestion, muscle contraction, and heartbeat.prognosis (prog-NO-sis) The likely outcome or course of a disease; the chance of recovery or recurrence.radioactive (RAY-dee-oh-AK-tiv) Giving off radiation.radioisotope (RAY-dee-oh-I-suh-tope) An unstable form of a chemical element that releases radiation as it breaks down and becomes more stable. Radioisotopes may occur in nature or be made in a laboratory. In medicine, they are used in imaging tests and in treatment. Also called radionuclide.radionuclide scanning (RAY-dee-oh-NOO-klide SKAN-ing) A procedure that produces pictures (scans) of structures inside the body, including areas where there are cancer cells. Radionuclide scanning is used to diagnose, stage, and monitor disease. A small amount of a radioactive chemical (radionuclide) is injected into a vein or swallowed. Different radionuclides travel through the blood to different organs. A machine with a special camera moves over the person lying on a table and detects the type of radiation given off by the radionuclides. A computer forms an image of the areas where the radionuclide builds up. These areas may contain cancer cells. Also called scintigraphy.rectum (REK-tum) The last several inches of the large intestine closest to the anus.recur (ree-KER) To come back or to return.recurrent cancer (ree-KER-ent KAN-ser) Cancer that has recurred (come back), usually after a period of time during which the cancer could not be detected. The cancer may come back to the same place as the original (primary) tumor or to another place in the body. Also called recurrence.risk factor (... FAK-ter) Something that increases the chance of developing a disease. Some examples of risk factors for cancer are age, a family history of certain cancers, use of tobacco products, being exposed to radiation or certain chemicals, infection with certain viruses or bacteria, and certain genetic changes.scanner (SKA-ner) In medicine, an instrument that takes pictures of the inside of the body.secretin (seh-KREE-tin) A hormone released into the blood by cells in the inner layer of the small intestine. It is released when partly digested food moves from the stomach into the small intestine. Secretin causes the pancreas, liver, and stomach to release other substances that help digest food. Secretin may also be made in the laboratory.secretin stimulation test (seh-KREE-tin STIM-yoo-LAY-shun …) A test used to help diagnose problems in the pancreas, such as gastrinomas and pancreatitis. It measures the ability of the pancreas to respond to the hormone secretin (a hormone that causes other substances to be released by the stomach, liver, and pancreas). Secretin is given to the patient by a tube put through the nose or throat into the small intestine and stomach or by injection into a vein. After a certain amount of time, samples are taken to be sent to a laboratory for testing. It is a type of pancreatic function test. Also called pancreatic function test.serum (SEER-um) The clear liquid part of the blood that remains after blood cells and clotting proteins have been removed.small intestine (... in-TES-tin) The part of the digestive tract that is located between the stomach and the large intestine.sodium (SOH-dee-um) A mineral needed by the body to keep body fluids in balance. Sodium is found in table salt and in many processed foods. Too much sodium can cause the body to retain water.somatostatin receptor scintigraphy (SOH-muh-toh-STA-tin reh-SEP-ter sin-TIH-gruh-fee) A type of radionuclide scan used to find carcinoid and other types of tumors. Radioactive octreotide, a drug similar to somatostatin, is injected into a vein and travels through the bloodstream. The radioactive octreotide attaches to tumor cells that have receptors for somatostatin. A radiation-measuring device detects the radioactive octreotide, and makes pictures showing where the tumor cells are in the body. Also called octreotide scan and SRS.sonogram (SAH-noh-gram) A computer picture of areas inside the body created by bouncing high-energy sound waves (ultrasound) off internal tissues or organs. Also called ultrasonogram.spine (spine) The bones, muscles, tendons, and other tissues that reach from the base of the skull to the tailbone. The spine encloses the spinal cord and the fluid surrounding the spinal cord. Also called backbone, spinal column, and vertebral column.stage (stayj) The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.stomach (STUH-muk) An organ that is part of the digestive system. The stomach helps digest food by mixing it with digestive juices and churning it into a thin liquid.stool (stool) The material in a bowel movement. Stool is made up of undigested food, bacteria, mucus, and cells from the lining of the intestines. Also called feces.surgery (SER-juh-ree) A procedure to remove or repair a part of the body or to find out whether disease is present. An operation.symptom (SIMP-tum) An indication that a person has a condition or disease. Some examples of symptoms are headache, fever, fatigue, nausea, vomiting, and pain.throat (throte) The hollow tube inside the neck that starts behind the nose and ends at the top of the trachea (windpipe) and esophagus (the tube that goes to the stomach). The throat is about 5 inches long, depending on body size. Also called pharynx.tissue (TIH-shoo) A group or layer of cells that work together to perform a specific function.ulceration (UL-seh-RAY-shun) The formation of a break on the skin or on the surface of an organ. An ulcer forms when the surface cells die and are cast off. Ulcers may be associated with cancer and other diseases.ultrasound (UL-truh-SOWND) A procedure in which high-energy sound waves are bounced off internal tissues or organs and make echoes. The echo patterns are shown on the screen of an ultrasound machine, forming a picture of body tissues called a sonogram. Also called ultrasonography.ultrasound transducer (UL-truh-SOWND tranz-DOO-ser) A device that produces sound waves that bounce off body tissues and make echoes. The transducer also receives the echoes and sends them to a computer that uses them to create a picture called a sonogram. Transducers (probes) come in different shapes and sizes for use in making pictures of different parts of the body. The transducer may be passed over the surface of the body or inserted into an opening such as the rectum or vagina.urine (YOOR-in) Fluid containing water and waste products. Urine is made by the kidneys, stored in the bladder, and leaves the body through the urethra.vasoactive intestinal peptide (VAY-zoh-AK-tiv in-TES-tih-nul PEP-tide) A hormone found in the pancreas, intestine, and central nervous system. It has many actions in the body, such as helping to control the secretion of water, salts, enzymes, and gastric acid during digestion. It also causes smooth muscles in the digestive tract, the heart, and the blood vessels to relax. It also has effects on the immune system and the central nervous system. Certain tumors in the pancreas make large amounts of vasoactive intestinal peptide. Also called VIP.vein (vayn) A blood vessel that carries blood to the heart from tissues and organs in the body.VIP A hormone found in the pancreas, intestine, and central nervous system. It has many actions in the body, such as helping to control the secretion of water, salts, enzymes, and gastric acid during digestion. It also causes smooth muscles in the digestive tract, the heart, and the blood vessels to relax. It also has effects on the immune system and the central nervous system. Certain tumors in the pancreas make large amounts of VIP. Also called vasoactive intestinal peptide.x-ray (EX-ray) A type of radiation used in the diagnosis and treatment of cancer and other diseases. In low doses, x-rays are used to diagnose diseases by making pictures of the inside of the body. In high doses, x-rays are used to treat cancer.Zollinger-Ellison syndrome (ZOLE-lin-jer-EH-lih-sun SIN-drome) A disorder in which tumors of the pancreatic islet cells produce large amounts of gastrin (a hormone), leading to excess acid in the stomach and, possibly, a peptic ulcer (ulcer of the stomach or the upper part of the small intestine). |
